We further identified increased promoter DMR methylation in prostate cancer correlating with decreased expression of mRNA and protein expression also on FBXO2, TGFB1I1, and TNS1 (Supplementary Fig. 4). The gene discussed is FBXO2; the disease is prostate cancer.